Table 2 Basal characteristics of study population.
NC (N = 45) | SCOPD (N = 42) | AECOPD (N = 66) | p value NC VS SCOPD | p value NC VS AECOPD | p value SCOPD VS AECOPD | |
|---|---|---|---|---|---|---|
Age (years) | 75.9 ± 2.66 | 78.4 ± 10.11 | 77.1 ± 9.12 | 0.758 | 0.802 | 0.889 |
Sex n (%) | ||||||
Male | 22 (48.9) | 30 (71.4) | 58 (87.9) | 0.052 | < 0.001 | 0.047 |
Female | 23 (51.1) | 12 (28.6) | 8 (12.1) | |||
WBC (× 109) | 5.96 ± 1.31 | 6.49 ± 2.48 | 7.86 ± 3.52 | 0.215 | < 0.001 | 0.010 |
NEU (× 109/L) | 3.53 ± 1.03 | 4.19 ± 1.68 | 6.34 ± 3.42 | 0.032 | < 0.001 | < 0.001 |
NLR | 2.12 ± 0.386 | 3.29 ± 2.71 | 9.25 ± 13.39 | 0.009 | < 0.001 | < 0.001 |
EO (× 109/L) | 0.13 ± 0.103 | 0.222 ± 0.529 | 0.15 ± 0.175 | 0.259 | 0.535 | 0.295 |
CRP (mg/dl) | 0.46 ± 0.35 | 1.17 ± 1.23 | 3.15 ± 4.34 | < 0.001 | < 0.001 | < 0.001 |
PCT (μg/L) | 0.068 ± 0.046 | 0.108 ± 0.139 | 0.20 ± 0.343 | 0.071 | 0.003 | 0.016 |
LDH (U/L) | 153.6 ± 16.55 | 208.8 ± 67.5 | 196.9 ± 44.8 | < 0.001 | < 0.001 | 0.422 |
SCOPD(%) | AECOPD(%) | p value | ||||
|---|---|---|---|---|---|---|
Comorbidities and complications | ||||||
Respiratory failure | 1 (0.03) | 36 (0.61) | < 0.001 | |||
Chronic pulmonary heart disease | 0 (0) | 9 (0.15) | 0.05 | |||
Autoimmune disease | 1 (0.03) | 2 (0.03) | 1.00 | |||
Cardiovascular disease | 13 (0.41) | 33 (0.56) | 0.163 | |||
Endocrine metabolic disease | 4 (0.13) | 17 (0.29) | 0.078 | |||
Cerebrovascular disease | 1 (0.03) | 14 (0.24) | 0.011 | |||
Neuropsychological disease | 3 (0.09) | 8 (0.14) | 0.804 | |||
Chronic nephrosis | 2 (0.06) | 8 (0.14) | 0.476 | |||
Chronic liver disease | 0 (0) | 4 (0.07) | 0.332 | |||
Chronic gastric disease | 0 (0) | 4 (0.07) | 0.332 |